New liver directed treatment improves outcomes for rare eye cancer
A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may...
rare
New vision for rare liver condition
Partner content: Ipsen UK Ltd worked with clinicians, patients and the PBC Foundation to arrange a meeting at the Scottish...
Global Liver Institute Champions Awareness for Rare Liver Diseases
February is Rare Liver Diseases Month! Join us this February as we launch #RareAware 2025, focusing on the unique experiences...
Elafibranor approved to treat adults with a rare liver disease known as primary biliary cholangitis
PBC is a type of chronic liver disease in which the small bile ducts in the liver become injured and...
New insights into rare liver cancer as clinical trial for treatment begins
Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few-in this case, children, adolescents,...
Ronnekleiv-Kelly Awarded Grant to Study Potential Treatment Target for Rare Form of Liver Cancer
Sean Ronnekleiv-Kelly, MD Division of Surgical Oncology Associate Professor Sean Ronnekleiv-Kelly, MD, is determined to improve treatment options for a...
